Calcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology.

Source:http://linkedlifedata.com/resource/pubmed/id/18674467

Download in:

View as

General Info

PMID
18674467